The Drug Development Core brings together the expertise of Roswell Park Comprehensive Cancer Center (RPCCC) and the UB School of Pharmacy and Pharmaceutical Sciences to provide a resource (including training) in preclinical and early clinical development of novel compounds for investigators as part of the Clinical and Translational Science Institute (CTSI).
We provide a centralized resource for preclinical pharmacology, pharmacokinetic-pharmacodynamics and early phase clinical trial design, conduct and management.
Drug Development Core requests can be submitted here through the CTSI request portal.
Funding for this project is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001412. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.